New drug shows promise for painful skin condition

NCT ID NCT05216224

Completed Disease control Sponsor: Aclaris Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether an experimental drug called ATI-450 could reduce painful skin lumps and improve quality of life for people with moderate-to-severe hidradenitis suppurativa. 95 participants received either the drug or a placebo for 12 weeks. Researchers measured changes in skin lesions, pain levels, and daily life impact to see if the treatment was effective and safe.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Aclaris Investigational Site

Birmingham, Alabama, 35244, United States
Aclaris Investigational Site

Fort Smith, Arkansas, 72916, United States
Aclaris Investigational Site

Encino, California, 91436, United States
Aclaris Investigational Site

San Francisco, California, 94115, United States
Aclaris Investigational Site

Thousand Oaks, California, 91436, United States
Aclaris Investigational Site

Boca Raton, Florida, 33486, United States
Aclaris Investigational Site

Hollywood, Florida, 33021, United States
Aclaris Investigational Site

Tampa, Florida, 33613, United States
Aclaris Investigational Site

Marietta, Georgia, 30060, United States
Aclaris Investigational Site

Sandy Springs, Georgia, 30328, United States
Aclaris Investigational Site

Metairie, Louisiana, 70006, United States
Aclaris Investigational Site

Fort Gratiot, Michigan, 48059, United States
Aclaris Investigational Site

Charlotte, North Carolina, 28277, United States
Aclaris Investigational Site

Athens, Ohio, 45701, United States
Aclaris Investigational Site

Mason, Ohio, 45040, United States
Aclaris Investigational Site

Hershey, Pennsylvania, 17033, United States
Aclaris Investigational Site

Anderson, South Carolina, 29621, United States
Aclaris Investigational Site

Nashville, Tennessee, 37215, United States
Aclaris Investigational Site

Houston, Texas, 77054, United States
Aclaris Investigational Site

Sugar Land, Texas, 77478, United States

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA